| P50 | author | Clemens Löwik | Q50637462 |
| P2093 | author name string | Papapoulos SE | |
| | Van Bezooijen RL | |
| P2860 | cites work | Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation | Q24311588 |
| | Osteoprotegerin: a novel secreted protein involved in the regulation of bone density | Q24313918 |
| | IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis | Q24563235 |
| | RANK is essential for osteoclast and lymph node development | Q24598872 |
| | Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand | Q24653311 |
| | Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids | Q29616817 |
| | The role of geranylgeranylation in bone resorption and its suppression by bisphosphonates in fetal bone explants in vitro: A clue to the mechanism of action of nitrogen-containing bisphosphonates | Q33861682 |
| | Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction | Q33886695 |
| | Inducible production of nitric oxide in osteoblast-like cells and in fetal mouse bone explants is associated with suppression of osteoclastic bone resorption | Q34138159 |
| | Interleukin-17-induced gene expression in articular chondrocytes is associated with activation of mitogen-activated protein kinases and NF-kappaB. | Q34474493 |
| | RelB, a new Rel family transcription activator that can interact with p50-NF-kappa B. | Q36812702 |
| | Osteoclastic inhibition: an action of nitric oxide not mediated by cyclic GMP | Q37470015 |
| | Cloning and characterization of inducible nitric oxide synthase from mouse macrophages | Q38329463 |
| | Osteoclast differentiation factor mediates an essential signal for bone resorption induced by 1 alpha,25-dihydroxyvitamin D3, prostaglandin E2, or parathyroid hormone in the microenvironment of bone | Q39116021 |
| | Expression of vascular endothelial growth factors and their receptors during osteoblast differentiation | Q40881030 |
| | Subcloning of three osteoblastic cell lines with distinct differentiation phenotypes from the mouse osteoblastic cell line KS-4. | Q41154242 |
| | Cloning of the murine relA (p65 NF-kappa B) gene and comparison to the human gene reveals a distinct first intron | Q41157973 |
| | In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria | Q41387920 |
| | Mechanisms controlling nitric oxide synthesis in osteoblasts | Q41403651 |
| | Cytokines induce nitric oxide production in mouse osteoblasts | Q41461166 |
| | The Michael Mason Prize Essay 1997. Nitric oxide and bone: what a gas! | Q41590242 |
| | Macrophage NO2- production as a sensitive and rapid assay for the quantitation of murine IFN-gamma | Q41683786 |
| | Interleukin-17: A new bone acting cytokine in vitro | Q42476956 |
| | In vitro and ex vivo evidence that estrogens suppress increased bone resorption induced by ovariectomy or PTH stimulation through an effect on osteoclastogenesis | Q42519431 |
| | Leukemia inhibitory factor inhibits osteoclastic resorption, growth, mineralization, and alkaline phosphatase activity in fetal mouse metacarpal bones in culture | Q46296488 |
| | Genomic organization and chromosomal mapping of mouse nuclear factor kappa B 2 (NFKB2). | Q47949209 |
| | Structure of wild-type and mutant mouse β2-microglobulin genes | Q48404514 |
| | Lipopolysaccharide treatment in vivo induces widespread tissue expression of inducible nitric oxide synthase mRNA. | Q50156368 |
| | IL-1alpha, IL-1beta, IL-6, and TNF-alpha steady-state mRNA levels analyzed by reverse transcription-competitive PCR in bone marrow of gonadectomized mice. | Q50903728 |
| | Interleukin-17 stimulates the expression of IkappaB alpha mRNA and the secretion of IL-6 and IL-8 in glioblastoma cell lines. | Q52030693 |
| | Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2. | Q52192178 |
| | Nitric oxide: a cytokine-induced regulator of bone resorption | Q71549011 |
| | Mechanisms of cytokine induced bone resorption: role of nitric oxide, cyclic guanosine monophosphate, and prostaglandins | Q71589434 |
| | Expression and functional role of nitric oxide synthase in osteoblast-like cells | Q71697513 |
| | The role of reactive oxygen intermediates in osteoclastic bone resorption | Q72548771 |
| | N-acetyl-L-cysteine enhances interleukin-1beta-induced nitric oxide synthase expression | Q73087422 |
| | Mitogen-activated protein kinase and nuclear factor kappaB together regulate interleukin-17-induced nitric oxide production in human osteoarthritic chondrocytes: possible role of transactivating factor mitogen-activated protein kinase-activated prot | Q73165868 |
| | NF-kappaB inhibitors stimulate apoptosis of rabbit mature osteoclasts and inhibit bone resorption by these cells | Q73545409 |
| | Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-kappaB ligand: modulation of the expression by osteotropic factors and cytokines | Q74269794 |
| | Required and nonessential functions of nuclear factor-kappa B in bone cells | Q78049289 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 378-386 | |
| P577 | publication date | 2001-04-01 | |
| P1433 | published in | Bone | Q15755003 |
| P1476 | title | Effect of interleukin-17 on nitric oxide production and osteoclastic bone resorption: is there dependency on nuclear factor-kappaB and receptor activator of nuclear factor kappaB (RANK)/RANK ligand signaling? | |
| P478 | volume | 28 | |